SP 600125
Tocris Bioscience | Catalog # 1496
Product Description
SP 600125 is a selective JNK inhibitor. Competitively and reversibly inhibits JNK1, 2 and 3 (IC50 = 40 - 90 nM) with negligible activity at ERK2, p38β and a range of enzymes. Active in vivo. Exhibits reduced selectivity over other protein kinases under certain conditions. SP 600125 protects renal tubular epithelial cells from ischemia/reperfusion-induced apoptosis. Promotes chondrogenesis of bone mesenchymal stem cells by inhibition of TNF-α-induced inflammation. Adipogenesis from MSCs is also promoted by SP 600125. Essential component of medium for maintaining stem cells in naive pluripotent state.
Product Specifications for SP 600125
Molecular Weight
Formula
Storage
Purity
Chemical Name
CAS Number
PubChem ID
InChI Key
SMILES
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 22.02 | 100 |
Preparing Stock Solutions for SP 600125
The following data is based on the product molecular weight 220.23.
Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 4.54 mL | 22.70 mL | 45.41 mL |
| 5 mM | 0.91 mL | 4.54 mL | 9.08 mL |
| 10 mM | 0.45 mL | 2.27 mL | 4.54 mL |
| 50 mM | 0.09 mL | 0.45 mL | 0.91 mL |
Calculators
Background References
References are publications that support the biological activity of the product. See our Citations tab to view 459 publications citing the usage of this product.
- Tominaga Negative regulation of adipogenesis from human mesenchymal stem cells by Jun N-terminal kinase. Biochem.Biophys.Res.Commun. 2005 PMID: 15582605
- Ding SP600125 restored TNF-α-induced impaired chondrogenesis in bone mesenchymal stem cells and its antiosteoarthritis effect in mice. Stem Cells Dev. 2021 PMID: 34486378
- Zhao Activation of JNKs is essential for BMP9-induced osteogenic differentiation of mesenchymal stem cells. BMB Rep. 2013 PMID: 23977991
- Wang SP600125, a selective JNK inhibitor, protects ischemic renal injury via suppressing the extrinsic pathways of apoptosis. Life Sci. 2007 PMID: 17459422
- Schnabl TAK1/JNK and p38 have opposite effects on rat hepatic stellate cells. Hepatology 2001 PMID: 11679966
- Bennett SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc.Natl.Acad.Sci.U.S.A. 2001 PMID: 11717429
Product Documents for SP 600125
Certificate of Analysis
To download a Certificate of Analysis, please enter a lot or batch number in the search box below.
Product Specific Notices for SP 600125
For research use only
Related Research Areas
Citations for SP 600125
Customer Reviews for SP 600125 (4)
Have you used SP 600125?
Submit a review and receive an Amazon gift card!
$25/€18/£15/$25CAN/¥2500 Yen for a review with an image
$10/€7/£6/$10CAN/¥1110 Yen for a review without an image
Submit a review
Customer Images
-
Species: HumanAssay Type: In VitroVerified Customer | Posted 05/31/2021Human cancer cells were pretreated for 2 hours with SP600125 before addition of chemotherapeutics and were incubated for 72 hours. SP600125 was used at 1, 3 and 10 μM. Real time apoptosis assays were performed. JNK inhibition partially reversed the chemotherapeutics-induced cellular apoptosis.
-
Species: MouseAssay Type: In VitroCell Line/Tissue: Primary murine microglia cellsVerified Customer | Posted 06/10/2019Primary murine microglia were treated with LPA (1µM) in the presence or absence of SP600125 (10µM) in order to investigate the role of JNK pathway in the LPA induced inflammatory phenotype. The inhibitor was well tolerated by the cells. DMSO was used as a vehicle control. Cells were lysed and collected for WB analysis in order to identify changes in the expression of COX2 and Arg1.
-
Species: MouseAssay Type: In VitroCell Line/Tissue: HL-1 cardiomyocytesVerified Customer | Posted 10/13/2018HL-1 cardiomyocytes were treated with SP 600125 (5 or 10 μM, 30 min) followed by 500 μg/ml HOCl-LDL (oxidant:lipoprotein molar ratio=800:1) for 1 h to follow pJNK expression using Western blot. SP 600125 at 10 μM concentration, completely inhibited activation of JNK.
-
Species: MouseAssay Type: In VitroCell Line/Tissue: BV2 microgliaVerified Customer | Posted 10/10/2018The inhibitor was used at a concentration of 10µM in BV2 microglia cell line. SP600125 inhibited the LPA induced activation of transcription factors (western blotting). It was also used in flow cytometry, ELISAs, IF and functional assays. The results were constant and reproducible.
There are no reviews that match your criteria.